Effects of Phytoadaptogen on Hepatoma Development in Cancer-Prone CBA Mice

O A Bocharova1, R V Karpova2, E V Bocharov2

  • 1N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia. imufarm@rambler.ru.

Insights

A complex phytoadaptogen reduced the occurrence, size, and number of liver cancers (hepatocarcinomas) in susceptible male mice. This natural compound showed both preventive and therapeutic effects against cancer development.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products

Background:

  • Hepatocarcinomas pose a significant health challenge.
  • Cancer-prone mouse models are crucial for studying carcinogenesis.
  • Phytoadaptogens are natural compounds with potential health benefits.

Purpose of the Study:

  • To investigate the efficacy of a complex phytoadaptogen in preventing and treating hepatocarcinomas.
  • To evaluate the impact of phytoadaptogen treatment on liver cancer incidence, size, and number.

Main Methods:

  • Utilized cancer-prone male CBA mice.
  • Administered a complex phytoadaptogen as both a preventive and therapeutic agent.
  • Monitored and quantified hepatocarcinoma development.

Main Results:

  • Significant decrease in the incidence of hepatocarcinomas observed.
  • Reduction in the average size of existing hepatocarcinomas.
  • Lowered number of hepatocarcinomas per mouse in the treatment groups.

Conclusions:

  • The complex phytoadaptogen demonstrated potent anti-hepatocarcinoma activity.
  • Phytoadaptogen treatment is effective in both preventing and reducing liver cancer burden.
  • These findings support the therapeutic potential of phytoadaptogens in oncology.